by adminTorusBrand | Jul 28, 2016 | HempMeds, HempMeds Brasil, HempMeds Mexico, Media Coverage, Press Releases
Medical Marijuana, Inc. CEO Dr. Stuart Titus and VP of Operations Blake Schroeder appeared on the Union Tribune’s Community Spotlight Radio Show yesterday in a unique interview that digs into the international growth, and the internal opportunities that the...
by adminTorusBrand | Jul 27, 2016 | Company News, HempMeds, HempMeds Brasil, HempMeds Mexico, Media Coverage
Our own Dr. Stuart Titus was featured on a recent episode of the San Diego Community Spotlight Show on wsRadio. Medical Marijuana, Inc. CEO Dr. Stuart Titus visited wsRadio’s U-T San Diego Community Spotlight Show this week to discuss the most recent cannabidiol (CBD)...
by adminTorusBrand | Jul 25, 2016 | Kannalife Sciences, Media Coverage, Press Releases, Scientific Research
Article Explains How Cannabis Could Be the “Holy Grail” of Neurological Medicine San Diego, CA – July 25, 2016 – Medical Marijuana, Inc. (OTC: MJNA) announced today that its portfolio company Kannalife Sciences, Inc. (“Kannalife”) was the focus of a Forbes article...
by adminTorusBrand | Jul 22, 2016 | Kannalife Sciences, Media Coverage
Medical Marijuana, Inc. CEO Stuart Titus was featured by Forbes this week, explaining Kannalife™ Sciences role in developing a pharmaceutical treatment for Chronic Traumatic Encephalopathy (CTE). CTE is a degenerative brain disorder caused by repeated brain trauma,...
by adminTorusBrand | Jul 14, 2016 | Company News, Kannalife Sciences, Media Coverage
Dean Petkanas and Thoma Kikis discuss the potential role cannabidiol (CBD) can play in the protection and treatment of NFL players from brain injury. What would it take for Kannalife™ Sciences to work with the NFL to put a stop to the out of control rate of...
by adminTorusBrand | Jul 14, 2016 | Kannalife Sciences, Media Coverage
Medical Marijuana, Inc. investment company Kannalife Sciences was featured by Sports Illustrated on SI.com, in an article entitled, “How cannabis is helping one company research treatment of CTE”. Read the article on SI.com here.
